Synpromics has entered a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals.    The 18-month project has been made possible through the award of a £235,000 grant, part of the medicines manufacturing competition from Innovate UK. Synpromics has employed its proprietary technology to develop new synthetic inducible/repressible cell-systems that are driven by non-toxic physiological or chemical stimulu...